Although the glutaminase inhibitor CB-839 had limited effect on HCC, it induced the apoptosis of HCC and inhibited HCC xenografts in mice when combined with V-9302, a novel inhibitor of glutamine transporter alanine-serine-cysteine transporter 2 [235]. The gene discussed is GLS; the disease is hepatocellular carcinoma.